Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer

dc.contributor.authors	Cokmert S, Demir L, Can A, Akyol M, Vedat Bayoglu I, Dirican A, Kucukzeybek Y, Erten C, Oktay Tarhan M.
dc.date.accessioned	2020-02-27T08:41:30Z
dc.date.available	2020-02-27T08:41:30Z
dc.date.issued	2014
dc.identifier.citation	Cokmert S, Demir L, Can A, Akyol M, Vedat Bayoglu I, Dirican A, Kucukzeybek Y, Erten C, Oktay Tarhan M. (2014). Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer. J BUON. , 19(1, 82-75
dc.identifier.uri	https://hdl.handle.net/20.500.12619/66727
dc.title	Capecitabine-related increased mean corpuscular volume of red blood cell may be a predictive marker of treatment response and survival in patients with metastatic colorectal cancer
dc.identifier.volume	19(1
dc.identifier.startpage	75
dc.identifier.endpage	82
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Bayoğlu, İbrahim Vedat
dc.relation.journal	J BUON.
dc.contributor.author	Bayoğlu, İbrahim Vedat